A LysLysLys-tag as trigger in polynorepinephrine epitope imprinting: The case study of soluble PD-L1 detection in serum by optical-based sensing.

[1]  P. Ross-Macdonald,et al.  Soluble PD-L1 as an early marker of progressive disease on nivolumab , 2022, Journal for ImmunoTherapy of Cancer.

[2]  M. Minunni,et al.  A biomimetic enzyme-linked immunosorbent assay (BELISA) for the analysis of gonadorelin by using molecularly imprinted polymer-coated microplates , 2022, Analytical and Bioanalytical Chemistry.

[3]  Li Dai,et al.  Soluble PD-L1 as a predictive biomarker in lung cancer: a systematic review and meta-analysis. , 2021, Future oncology.

[4]  Dong-Wan Kim,et al.  Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment , 2021, Scientific Reports.

[5]  A. Llombart-Cussac,et al.  Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy , 2021, Cancers.

[6]  M. Minunni,et al.  Sensitive 'two-steps' competitive assay for gonadotropin-releasing hormone detection via SPR biosensing and polynorepinephrine-based molecularly imprinted polymer. , 2021, Analytica chimica acta.

[7]  Fangying Wu,et al.  Polydopamine molecularly imprinted polymer coated on a biomimetic iron-based metal-organic framework for highly selective fluorescence detection of metronidazole. , 2021, Talanta.

[8]  V. Thu,et al.  Epitope-imprinted polydopamine electrochemical sensor for ovalbumin detection. , 2021, Bioelectrochemistry.

[9]  M. Minunni,et al.  Detection of canine and equine procalcitonin for sepsis diagnosis in veterinary clinic by the development of novel MIP-based SPR biosensors. , 2021, Talanta.

[10]  S. Schmidt,et al.  Sequence-defined positioning of amine and amide residues to control catechol driven wet adhesion† , 2020, Chemical science.

[11]  P. Messersmith,et al.  Molecular design principles of Lysine-DOPA wet adhesion , 2020, Nature Communications.

[12]  H. Matsubara,et al.  Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer , 2020, Oncology letters.

[13]  M. Gross,et al.  Epitope and Paratope Mapping of PD-1/Nivolumab by Mass Spectrometry-based Hydrogen/Deuterium Exchange, Cross-linking, and Molecular Docking. , 2020, Analytical chemistry.

[14]  M. Minunni,et al.  Norepinephrine as new functional monomer for molecular imprinting: An applicative study for the optical sensing of cardiac biomarkers. , 2020, Biosensors & bioelectronics.

[15]  Y. Ko,et al.  Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma , 2019, BMC Cancer.

[16]  H. Cha,et al.  The position of lysine controls the catechol-mediated surface adhesion and cohesion in underwater mussel adhesion. , 2019, Journal of colloid and interface science.

[17]  C. Stubbs,et al.  Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies , 2019, Modern Pathology.

[18]  N. Tsoukalas,et al.  PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[19]  Yongshuai Jiang,et al.  PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations , 2019, Human vaccines & immunotherapeutics.

[20]  M. Minunni,et al.  Cardiac Troponin T capture and detection in real-time via epitope-imprinted polymer and optical biosensing. , 2018, Biosensors & bioelectronics.

[21]  Yi Cao,et al.  Hidden complexity of synergistic roles of Dopa and lysine for strong wet adhesion , 2017 .

[22]  J. Lang,et al.  Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer. , 2017, Oncotarget.

[23]  A. Giobbie-Hurder,et al.  Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade , 2017, Cancer Immunology Research.

[24]  T. Janowitz,et al.  A molecular and preclinical comparison of the PD-1–targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab , 2017, Seminars in oncology.

[25]  V. Heinemann,et al.  Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer , 2017, Oncoimmunology.

[26]  Jacquelyn Smith,et al.  Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N , 2016, Diagnostic Pathology.

[27]  F. Greten,et al.  High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis. , 2016, European journal of cancer.

[28]  Zhaohui Zhang,et al.  Magnetic molecularly imprinted polydopamine nanolayer on multiwalled carbon nanotubes surface for protein capture. , 2015, Talanta.

[29]  A. Butler,et al.  Adaptive synergy between catechol and lysine promotes wet adhesion by surface salt displacement , 2015, Science.

[30]  S. Costantini,et al.  The N‐terminal Region of CXCL11 as Structural Template for CXCR3 Molecular Recognition: Synthesis, Conformational Analysis, and Binding Studies , 2012, Chemical biology & drug design.

[31]  V. Trezza,et al.  Human serum albumin: from bench to bedside. , 2012, Molecular aspects of medicine.

[32]  Yan Zhang,et al.  Sensing HIV related protein using epitope imprinted hydrophilic polymer coated quartz crystal microbalance. , 2012, Biosensors & bioelectronics.

[33]  L. Hellman,et al.  Hexahistidine-tag-specific optical probes for analyses of proteins and their interactions. , 2010, Analytical biochemistry.